Press release no 2 -2015
Targovax has appointed two highly experienced executives to key leadership roles in the company, effective from January 5th, 2015
Press release no 6-2014
Targovax is one of the winners of Immuno-Oncology Innovation Projects, awarded by Oslo Cancer Cluster and Innovation Norway, in competition with many other high quality projects.
Targovax: Interim Report Q2 and YTD 2014 (PDF)Read more
Targovax will participate at the DNB Markets Health Care Conference 2014, December 11th 2014, Oslo, NorwayRead more
Press release no 5-2014
The board of Targovax is pleased to announce Mr. Gunnar Gårdemyr as the new CEO of the company from January 12th, 2015.
Mr Gårdemyr has more than 30 years of international experience from the pharmaceutical and biotech industry.Read more